IL6 and atrial fibrillation: Clinical studies support this view by revealing a predictive role of biomarkers such as C-reactive protein (CRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α with respect to AF occurrence, persistence, recurrence and left atrial dimensions.